| BetaShares Western Asset Australian Bond Fund (Managed Fund) (BNDS) |
Financials |
$857 |
Estimated Distribution Announcement
|
26 Feb 2026 5:16PM |
$23.490 |
$23.440 |
fallen by
0.21%
|
|
| Novo Resources Corp. (NVO) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$9 |
Update - Proposed issue of securities - NVO
|
26 Feb 2026 5:14PM |
$0.135 |
$0.066 |
fallen by
51.11%
|
|
| Novo Resources Corp. (NVO) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$9 |
Update - Proposed issue of securities - NVO
|
26 Feb 2026 5:14PM |
$0.135 |
$0.066 |
fallen by
51.11%
|
|
| Aland Equity Group Limited (AEG) ORDINARY FULLY PAID |
Financials |
$54 |
Appendix 4D and Interim Report
|
26 Feb 2026 5:14PM |
$0.034 |
$0.072 |
risen by
111.76%
|
|
AEG - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating loss after tax was $1,694,821.
- Revenue decreased by 41.7% to $276,343.
- 12% increase in funds under management with $7.04m.
- Equity Story Growth Fund's performance below the benchmark for the year but above since inception.
- Significant directorate changes during the period.
- Report prepared on a going concern basis with significant cash from financing activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BetaShares Australian High Interest Cash ETF (AAA) |
Financials |
$4,996 |
Estimated Distribution Announcement
|
26 Feb 2026 5:12PM |
$50.230 |
$50.230 |
fallen by
0%
|
|
| Betashares Australian Cash Plus Fund (Managed Fund) (MMKT) |
Financials |
$595 |
Estimated Distribution Announcement
|
26 Feb 2026 5:12PM |
$50.160 |
$50.190 |
risen by
0.06%
|
|
| Cavalier Resources Limited (CVR) ORDINARY FULLY PAID |
Materials |
$17 |
Half Year Accounts
|
26 Feb 2026 5:12PM |
$0.380 |
$0.195 |
fallen by
48.68%
|
|
| Iron Bear Resources Ltd (IBR) ORDINARY FULLY PAID |
Materials |
$80 |
Appendix 3Y - Luke Martino
|
26 Feb 2026 5:11PM |
$0.047 |
$0.072 |
risen by
53.19%
|
|
| Iron Bear Resources Ltd (IBR) ORDINARY FULLY PAID |
Materials |
$80 |
Appendix 3Y - David Sanders
|
26 Feb 2026 5:10PM |
$0.047 |
$0.072 |
risen by
53.19%
|
|
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$75 |
Notification regarding unquoted securities - PHO
|
26 Feb 2026 5:09PM |
$0.115 |
$0.140 |
risen by
21.74%
|
|
| Embark Early Education Limited (EVO) ORDINARY FULLY PAID |
Consumer Discretionary |
$81 |
Notice of Status of Defeating Conditions
|
26 Feb 2026 5:09PM |
$0.550 |
$0.400 |
fallen by
27.27%
|
|
EVO - Price-sensitive ASX Announcement
Full Release
Key Points
- Embark Early Education Limited is making an off-market takeover bid for Mayfield Childcare Limited.
- The bid is made under the Corporations Act 2001.
- All defeating conditions, except the quotation condition, have been fulfilled or waived.
- Embark's current voting power in Mayfield is 20.45%.
- The offer includes a choice between scrip consideration and cash payment for Mayfield shares.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayfield Childcare Limited (MFD) ORDINARY FULLY PAID |
Consumer Discretionary |
$12 |
EVO: Notice of Status of Defeating Conditions
|
26 Feb 2026 5:09PM |
$0.495 |
$0.160 |
fallen by
67.68%
|
|
MFD - Price-sensitive ASX Announcement
Full Release
Key Points
- Notice of status of defeating conditions for the bid.
- Offer made under Chapter 6 of the Corporations Act.
- Defeating conditions have been waived, except for quotation condition.
- Embark's voting power in Mayfield is at 20.45%.
- Takeover offer is for all ordinary shares of Mayfield Childcare Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Domino's Pizza Enterprises Limited (DMP) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,535 |
Change in substantial holding
|
26 Feb 2026 5:08PM |
$20.840 |
$16.200 |
fallen by
22.26%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$8 |
Change in substantial holding
|
26 Feb 2026 5:07PM |
$0.003 |
$0.002 |
fallen by
40%
|
|
| Iron Bear Resources Ltd (IBR) ORDINARY FULLY PAID |
Materials |
$80 |
Notification regarding unquoted securities - IBR
|
26 Feb 2026 5:05PM |
$0.047 |
$0.072 |
risen by
53.19%
|
|
| Nanosonics Limited (NAN) ORDINARY FULLY PAID |
Health Care |
$980 |
Becoming a substantial holder
|
26 Feb 2026 5:04PM |
$3.250 |
$3.280 |
risen by
0.92%
|
|
| Orbital Corporation Limited (OEC) ORDINARY FULLY PAID |
Industrials |
$27 |
Half Yearly Report and Accounts
|
26 Feb 2026 5:01PM |
$0.110 |
$0.150 |
risen by
36.36%
|
|
OEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported a loss of $1,496,000 for the half-year ended 31 December 2025.
- Revenue from continuing operations was $4,892,000.
- Raised $3 million from equity placement for engine development.
- Remains debt-free with undrawn $2 million standby loan.
- Focus on expanding customer base and leveraging technology.
- Entered financing arrangement with Radium Capital for R&D.
- Advancing development of larger engine platforms.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$353 |
Letter to Shareholders
|
26 Feb 2026 5:00PM |
$0.140 |
$0.155 |
risen by
10.71%
|
|
| Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$5 |
Half Yearly Report and Accounts
|
26 Feb 2026 5:00PM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
BIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Biotron Limited reported a loss of $920,969 for the half-year ended 31 December 2025.
- The company acquired Sedarex Limited, issuing 500,000,000 ordinary shares as part of the transaction.
- Biotron completed a rights issue and raised $1,523,860, including a shortfall allocation.
- The company focused on advancing its lead HBV drug, BIT-HBV001, which showed promising results in preclinical studies.
- Dr. Paul Kasian was appointed as a Non-Executive Director on 23 December 2025.
- Cash and cash equivalents increased to $1,642,799 as of 31 December 2025.
- Biotron continued its collaboration with US-based C14 Consulting Group for commercialization activities.
- The acquisition of Sedarex includes contingent consideration based on achieving certain milestones related to its SedRx general anaesthetic product.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Inghams Group Limited (ING) ORDINARY FULLY PAID |
Consumer Staple |
$734 |
Becoming a substantial holder
|
26 Feb 2026 4:58PM |
$2.070 |
$1.975 |
fallen by
4.59%
|
|
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,059 |
Change in substantial holding from MUFG
|
26 Feb 2026 4:56PM |
$19.400 |
$20.690 |
risen by
6.65%
|
|
| Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$24 |
Appendix 4D and Interim Financial Report 31 Dec 2025
|
26 Feb 2026 4:55PM |
$0.013 |
$0.009 |
fallen by
30.77%
|
|
DUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Dubber Corporation Limited reported a revenue of $18,698,469 for the period ending 31 December 2025, down from $20,521,713 in the previous year.
- Direct costs decreased to $5,634,317 from $6,520,178, resulting in revenue less direct costs of $13,064,152.
- The company reported a net loss before income tax of $4,449,380, down from $11,546,353 in 2024.
- Total comprehensive loss attributable to owners was $4,219,493 compared to $11,777,310 in the previous year.
- The basic and diluted loss per share reduced to 0.16 cents from 0.88 cents.
- Cash and cash equivalents stood at $7,341,439 as of 31 December 2025, compared to $10,863,888 on 30 June 2025.
- Net assets were $11,177,647, a decrease from $13,921,027.
- Issued capital increased to $355,997,315 from $353,232,255, with a total of 2,701,572,524 ordinary shares fully paid at the end of the period.
- The report includes a statement of changes in equity, noting significant transactions with directors involving share subscriptions and share-based payments.
- Directors expressed confidence in the company's ability to meet its debts as they fall due for a period of at least 12 months following the report's issuance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVADA Group Limited (AVD) ORDINARY FULLY PAID |
Industrials |
$8 |
1H FY26 financial results investor presentation
|
26 Feb 2026 4:54PM |
$0.125 |
$0.100 |
fallen by
20%
|
|
AVD - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong revenue growth and improved operating efficiencies.
- Significant financial achievements in 1H FY26.
- Robust increase in revenue driven by organic growth and strategic acquisitions.
- Focus on enhancing service offerings and expanding market presence.
- Continued investments in technology and infrastructure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVADA Group Limited (AVD) ORDINARY FULLY PAID |
Industrials |
$8 |
1H FY26 financials reports improving operating performance
|
26 Feb 2026 4:53PM |
$0.125 |
$0.100 |
fallen by
20%
|
|
AVD - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating revenue increased by 11% to $101.5 million.
- Statutory loss after tax was $16.5 million due to a $15 million non-cash impairment.
- Adjusted EBITDA of $7.1 million achieved through strong revenue growth.
- Strong revenue performance in Queensland and New South Wales.
- Challenging conditions in Victoria due to unionized labor requirements.
- Economic challenges persist in New Zealand.
- Leadership changes include Dan Crowley's transition to Executive Director.
- Transformation initiatives expected to deliver benefits in H2 FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PTR Minerals Ltd (PTR) ORDINARY FULLY PAID |
Materials |
$37 |
Section 708A Notice - Share Issue
|
26 Feb 2026 4:49PM |
$0.220 |
$0.093 |
fallen by
57.73%
|
|